JNBA Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$706K Buy
5,494
+53
+1% +$6.2K 0.05% 124
2026
Q1
$654K Sell
5,441
-299
-5% -$34.5K 0.05% 127
2025
Q4
$604K Buy
5,740
+45
+0.8% +$4.22K 0.05% 132
2025
Q3
$478K Hold
5,695
0.04% 137
2025
Q2
$451K Hold
5,695
0.04% 140
2025
Q1
$511K Hold
5,695
0.05% 127
2024
Q4
$567K Sell
5,695
-93
-2% -$9.59K 0.06% 124
2024
Q3
$657K Sell
5,788
-48
-0.8% -$5.7K 0.07% 116
2024
Q2
$722K Sell
5,836
-200
-3% -$25.8K 0.08% 110
2024
Q1
$796K Sell
6,036
-345
-5% -$42.5K 0.08% 110
2023
Q4
$696K Buy
6,381
+4
+0.1% +$415 0.08% 117
2023
Q3
$656K Sell
6,377
-46
-0.7% -$4.96K 0.08% 117
2023
Q2
$741K Buy
6,423
+50
+0.8% +$5.68K 0.09% 113
2023
Q1
$678K Sell
6,373
-479
-7% -$51.7K 0.09% 113
2022
Q4
$760K Sell
6,852
-1,303
-16% -$133K 0.11% 112
2022
Q3
$702K Sell
8,155
-247
-3% -$22.1K 0.11% 110
2022
Q2
$766K Sell
8,402
-170
-2% -$15.1K 0.12% 100
2022
Q1
$703K Sell
8,572
-247
-3% -$19.5K 0.09% 113
2021
Q4
$676K Buy
8,819
+296
+3% +$23.6K 0.08% 113
2021
Q3
$640K Buy
8,523
+790
+10% +$60.1K 0.09% 111
2021
Q2
$601K Buy
7,733
+1,010
+15% +$75.1K 0.08% 108
2021
Q1
$494K Buy
6,723
+1,405
+26% +$104K 0.07% 119
2020
Q4
$415K Buy
5,318
+96
+2% +$7.34K 0.07% 121
2020
Q3
$413K Sell
5,222
-45
-0.9% -$3.52K 0.08% 106
2020
Q2
$389K Buy
5,267
+52
+1% +$3.92K 0.08% 107
2020
Q1
$383K Hold
5,215
0.09% 102
2019
Q4
$453K Buy
5,215
+173
+3% +$14.2K 0.09% 104
2019
Q3
$405K Buy
5,042
+150
+3% +$12K 0.08% 103
2019
Q2
$391K Buy
4,892
+616
+14% +$47.2K 0.08% 109
2019
Q1
$339K Buy
4,276
+1,619
+61% +$121K 0.07% 109
2018
Q4
$194K Sell
2,657
-6,750
-72% -$477K 0.04% 131
2018
Q3
$637K Buy
9,407
+6,400
+213% +$408K 0.29% 66
2018
Q2
$174K Hold
3,007
0.04% 136
2018
Q1
$156K Sell
3,007
-68
-2% -$3.67K 0.03% 139
2017
Q4
$165K Sell
3,075
-157
-5% -$8.7K 0.03% 138
2017
Q3
$197K Buy
3,232
+275
+9% +$16.7K 0.04% 120
2017
Q2
$181K Hold
2,957
0.04% 124
2017
Q1
$179K Buy
2,957
+116
+4% +$7.04K 0.04% 124
2016
Q4
$160K Sell
2,841
-14,674
-84% -$859K 0.04% 128
2016
Q3
$1.04M Buy
17,515
+14,358
+455% +$840K 0.15% 45
2016
Q2
$174K Buy
3,157
+96
+3% +$5.11K 0.05% 125
2016
Q1
$155K Sell
3,061
-879
-22% -$43K 0.06% 121
2015
Q4
$199K Buy
3,940
+818
+26% +$41.2K 0.08% 99
2015
Q3
$147K Buy
3,122
+835
+37% +$44.4K 0.06% 112
2015
Q2
$124K Hold
2,287
0.05% 115
2015
Q1
$125K Hold
2,287
0.05% 115
2014
Q4
$124K Sell
2,287
-314
-12% -$17.5K 0.05% 122
2014
Q3
$147K Buy
2,601
+697
+37% +$39.1K 0.07% 110
2014
Q2
$105K Buy
1,904
+110
+6% +$6K 0.05% 125
2014
Q1
$97K Hold
1,794
0.05% 119
2013
Q4
$86K Buy
1,794
+527
+42% +$24.1K 0.05% 130
2013
Q3
$58K Hold
1,267
0.04% 152
2013
Q2
$56K Buy
+1,267
New +$56.6K 0.04% 146

Other funds holding MRK

JNBA Financial Advisors's MRK Position: Q2 2026 in Review

JNBA Financial Advisors increased its Merck (MRK) stake by 0.97% in Q2 2026, buying an estimated $6.2K and bringing the position to 5,494 shares worth $706K. The position accounts for 0.05% of the portfolio, ranked #124.

JNBA Financial Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.04M in Q3 2016. 1,410 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • JNBA Financial Advisors held 5,494 shares of Merck worth $706K as of Q2 2026.
  • JNBA Financial Advisors bought 53 Merck shares in Q2 2026, an estimated $6.2K.
  • Merck made up 0.05% of JNBA Financial Advisors's portfolio in Q2 2026, its #124 holding.
  • JNBA Financial Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • JNBA Financial Advisors's Merck position peaked at $1.04M in Q3 2016.
  • 1,410 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.